AIDS Vaccine Week
Susan Hasty, Publisher
Table of Contents . . . January 26th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Vaccine Week | Other Publications
HIV/AIDS Vaccine - Ii-Key/MHC class II epitope hybrid peptide vaccines show promise for HIV
HIV/AIDS Therapy - Patterns of NRTI cross-resistance identified
Healthcare Access - ARV rollouts in 2003 bring rising hope in South Africa
Healthcare Access - Zimbabwe: High costs hamper access to ARVs
Legislation - Bill targets willful spreading of HIV
HIV/AIDS Vaccine - Scientific challenges impeding HIV vaccine development reviewed
AIDS Vaccine - GenVec, NIH expand contract to include late-stage manufacturing for HIV vaccine
RNA Research - Novel assay measures small molecule RNA binding
AIDS Testing - VScan maker to begin last phase of testing in the United States
Drug Development - Novel thymine nucleosides fail to show antiviral activity
HIV/AIDS Receptor Studies - Structure of gp120-CCR5 complex elucidated
HIV/AIDS Therapy - CD4 cell nadir predicts response to subcutaneous rIL-2 treatment
HIV/AIDS Therapy - Novel strategies show promise for eradicating latent HIV infection
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
